2020-09-10 07:02:50 LLY Eli Lilly
09/10/20 09/1007:02 09/10/2007:02 | Eli Lilly to present new data from cancer research pipeline at ESMOData from 20 studies across Eli Lilly's oncology product portfolio will be presented at the European Society for Medical Oncology, or ESMO, virtual congress, September 19-21. The data include results from the Phase 3 monarchE study of Verzenio in combination with standard adjuvant endocrine therapy, or ET, for the treatment of high risk HR+, HER2- early breast cancer. Lilly continues to investigate Verzenio across the breast cancer continuum, which has now shown results in people with high risk HR+, HER2- early breast cancer. At ESMO, Lilly will share detailed results from the Phase 3 monarchE study, which demonstrated Verzenio plus standard adjuvant ET significantly decreased the risk of breast cancer recurrence compared to standard adjuvant ET alone in people with high risk HR+, HER2- early breast cancer. These results make Verzenio the only CDK4 & 6 inhibitor to demonstrate statistically significant improvement in invasive disease-free survival in this setting. Lilly also will present findings on genomic testing, biomarkers and treatment patterns in early breast cancer as well as the use of Ki-67 testing and scoring in HR+, HER2- early breast cancer - a biomarker of particular interest in the study of high risk early breast cancer. Additional Verzenio data to be presented include a final overall survival analysis of Verzenio monotherapy in patients with HR+, HER2- advanced breast cancer in the nextMONARCH trial. The approval of Retevmo - a selective RET kinase inhibitor - marked the most rapid timeline in the development of an oncology medicine with multiple indications, and was based on results from the Phase 1/2 LIBRETTO-001 trial, the largest clinical trial in patients with RET-altered cancers. During ESMO, Lilly will present patient-reported outcomes and quality of life findings from both the RET fusion-positive NSCLC and RET-mutant MTC patient cohorts. Lilly will also present new safety data on patients with previously treated metastatic RET fusion-positive NSCLC, including safety and efficacy outcomes assessed by category of last systemic therapy received prior to LIBRETTO-001 enrollment. An additional safety analysis, focusing on hypersensitivity reactions in RET fusion-positive NSCLC patients previously treated with immune checkpoint inhibitors, will also be presented. Details on the study design of two confirmatory Phase 3 trials, LIBRETTO-431 and LIBRETTO-531, will additionally be shared. Both Phase 3 trials are currently enrolling patients. Earlier this year, the FDA approved CYRAMZA in combination with erlotinib for the first-line treatment of people with metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) mutations, based on results from the Phase 3 RELAY study. With this approval, CYRAMZA has now received six FDA approvals to treat certain types of lung, liver, stomach and colorectal cancers. CYRAMZA was also approved in the European Union earlier this year based on the RELAY results. During ESMO, Lilly will feature data from the RELAY trial looking at outcomes by EGFR mutation type in previously untreated EGFR-mutated metastatic NSCLC patients. Additionally, a systematic literature review will spotlight outcomes of treated patients with EGFR-mutated NSCLC harboring exon 19 deletions or exon 21 mutations. |
|
---|
Hot Stocks
|
Smart for Life Inc trading halted, news pending
19:50
04/19/24
04/19
19:50
04/19/2419:50
SMFL
Smart for Life
|
Hot Stocks
|
Windtree Therapeutics Inc trading halted, news pending
19:50
04/19/24
04/19
19:50
04/19/2419:50
WINT
Windtree Therapeutics
|
Hot Stocks
|
Portland General Electric raises quarterly dividend 5.3% to 50c per share »
18:04
04/19/24
04/19
18:04
04/19/2418:04
POR
Portland General Electric
On April 19, the board of… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
NovaBay receives NYSE American notice of non-compliance »
18:01
04/19/24
04/19
18:01
04/19/2418:01
NBY
NovaBay
NovaBay Pharmaceuticals… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Oragenics announces NYSE American noncompliance notification »
17:53
04/19/24
04/19
17:53
04/19/2417:53
OGEN
Oragenics
Oragenics announced that… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Wrap Technologies receives noncompliance notification from Nasdaq »
17:30
04/19/24
04/19
17:30
04/19/2417:30
WRAP
Wrap Technologies
Wrap Technologies… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
HII awarded $120.3M Navy contract modification »
17:25
04/19/24
04/19
17:25
04/19/2417:25
HII
HII
HII was awarded a $120.3M… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Arista Networks COO Anshul Sadana to resign, effective May 21 »
17:19
04/19/24
04/19
17:19
04/19/2417:19
ANET
Arista Networks
In a regulatory filing,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Syndicate
|
InnSuites Hospitality Trust files to sell 1M shares of common stock
17:16
04/19/24
04/19
17:16
04/19/2417:16
IHT
InnSuites Hospitality Trust
|
Syndicate
|
Inhibikase Therapeutics files to sell common stock, warrants, no amount given »
17:16
04/19/24
04/19
17:16
04/19/2417:16
IKT
Inhibikase Therapeutics
Maxim Group is acting as… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Aslan Pharmaceuticals receives Nasdaq notice »
17:13
04/19/24
04/19
17:13
04/19/2417:13
ASLN
Aslan Pharmaceuticals
Aslan Pharmaceuticals… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Syndicate
|
Zai Lab files automatic ordinary shares offering
17:13
04/19/24
04/19
17:13
04/19/2417:13
ZLAB
Zai Lab
|
Syndicate
|
Endra Life Sciences files to sell common stock, warrants, no amount given »
17:12
04/19/24
04/19
17:12
04/19/2417:12
NDRA
Endra Life Sciences
Craig-Hallum is sole… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Hepion Pharmaceuticals falls 42% after wind down of ASCEND-NASH trial »
17:08
04/19/24
04/19
17:08
04/19/2417:08
HEPA
Hepion Pharmaceuticals
In after-hours trading,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
NLS Pharmaceutics receives staff delisting determination letter from Nasdaq »
17:05
04/19/24
04/19
17:05
04/19/2417:05
NLSP
NLS Pharmaceutics
NLS Pharmaceutics… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Conference/Events
|
Steelcase management to meet with Benchmark »
17:04
04/19/24
04/19
17:04
04/19/2417:04
SCS
Steelcase
Group breakfast at 7:45am… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Syndicate
|
AIM ImmunoTech files to sell 9.98M shares of common stock for holders
17:03
04/19/24
04/19
17:03
04/19/2417:03
AIM
AIM ImmunoTech
|
Hot Stocks
|
Lion Group receives noncompliance notification from Nasdaq »
17:03
04/19/24
04/19
17:03
04/19/2417:03
LGHL
Lion Group
Lion Group announced that… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Syndicate
|
RenovoRx files to sell 6.13M shares of common stock for holders
17:03
04/19/24
04/19
17:03
04/19/2417:03
RNXT
RenovoRx
|
Syndicate
|
Yoshiharu files to sell 237,885 shares of Class A common stock for holders
17:02
04/19/24
04/19
17:02
04/19/2417:02
YOSH
Yoshiharu
|
Hot Stocks
|
Hepion Pharmaceuticals trading resumes
17:00
04/19/24
04/19
17:00
04/19/2417:00
HEPA
Hepion Pharmaceuticals
|
General news
|
Treasury Market Summary: »
16:55
04/19/24
04/19
16:55
04/19/2416:55
$ECON
Economic Data
Treasury Market Summary:… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Conference/Events
|
Oppenheimer healthcare analysts hold an analyst/industry conference callssssssss »
16:51
04/19/24
04/19
16:51
04/19/2416:51
Healthcare Analysts,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Asbury Automotive chief legal officer George Villasana to retire »
16:40
04/19/24
04/19
16:40
04/19/2416:40
ABG
Asbury Automotive
Asbury Automotive… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Conference/Events
|
Editas Medicine management to meet with Oppenheimer »
16:36
04/19/24
04/19
16:36
04/19/2416:36
EDIT
Editas Medicine
Meeting to be held on… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |